Biography of William Ludlam
Last update: November 8, 2023Career
William was Senior Medical Director at Novartis, and Medical Director at Swedish Medical Center. William Ludlam joined CVC Capital Partners in 2015. William served as Vice President, Medical Affairs and Vice President, Clinical Development and Medical Affairs for CVC Capital Partners.
William Ludlam is currently Chief Medical Officer and Vice President, Clinical Development at Recordati Rare Diseases - View - Recordati Rare Diseases org chart
Create your alert
to follow the career of William Ludlam.
Education
William Ludlam has a PhD in Developmental Neuroscience & Molecular Biology from Doctor of Philosophy (Ph.D.)Field Of StudyDevelopmental Neuroscience/Molecular Biology and a Doctor of Medicine in Medicine from Albert Einstein College of Medicine of Yeshiva University.
They have also studied at Albert Einstein College of Medicine of Yeshiva University :
- Perry Nisen - Teva Pharmaceutical Industries
- Noreen Henig - Avidity Biosciences
- Ian Walters - Portage Biotech
Find more alumni from Albert Einstein College of Medicine of Yeshiva University
More about William Ludlam
Do you need to know more about William Ludlam? More results.
Participate
Social media
- William Ludlam on Google News, Twitter, LinkedIn, YouTube
- View the pictures of William Ludlam
The colleagues of William Ludlam
Company Colleagues
- At Recordati Rare Diseases, William Ludlam has 10 colleagues including Luigi Longinotti (EMEA), Scott Pescatore (Operations)…
Industry Colleagues
- In the Pharmaceuticals industry, William Ludlam has 19,315 colleagues in 1,862 companies located in 69 countries. 8,417 executive movements have been recorded in the last 12 months. Learn more about Pharmaceuticals.
Report an error
Update the org chart details of William Ludlam.
Get in Touch
Sorry, but William Ludlam cannot be contacted yet through our email service. Please use our Premium/VIP service to join colleagues of William Ludlam listed below. Here are a few tips for establishing great contacts.
